Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Crohn’s & Colitis Foundation Receives $3.3 Million from The Helmsley Charitable Trust to Improve Urgent Care Management of Crohn’s Disease

The Crohn’s & Colitis Foundation announced today that it has received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to improve the urgent care management of Crohn’s disease through IBD Qorus®, the Foundation’s flagship quality of care program. 

May 12, 2021

Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD

Progenity, Inc., a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop Progenity’s first-in-class oral Drug Delivery System (DDS) for delivery of targeted therapeutics for inflammatory bowel disease (IBD).

May 11, 2021

Crohn’s & Colitis Foundation Names New Board Chair, Elects Three New Trustees

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that Dr. Brent Polk (University of California San Diego) has been appointed Chair of its national Board of Trustees, and that three new trustees have been elected to the Board.

March 11, 2021

New Partnership Announced to Develop First Prognostic Tests for Pediatric Crohn's Disease

The Crohn's and Colitis Foundation enters partnership with LifeArc to develop first clinical tests to predict disease course and response to treatment in pediatric Crohn's patients.

January 25, 2021

Crohn’s & Colitis Foundation and Pfizer, Inc. Announce Funding Awards to Reduce Health Disparities in Patients with Inflammatory Bowel Disease

NEW YORK, NY – The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer Inc., has announced the results of a request for proposal (RFP) to reduce health disparities that exist around vaccine usage and health maintenance in patients with inflammatory bowel disease (IBD). 

October 7, 2020

ACG and The Crohn’s & Colitis Foundation Publish Entrustable Professional Activities for Advanced IBD Fellowship Training in the U.S.

The American College of Gastroenterology (ACG) and The Crohn’s & Colitis Foundation (the Foundation) are proud to announce their joint publication of “Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States” in both

August 25, 2020

Inflammatory Bowel Diseases—an official journal of Crohn’s & Colitis Foundation—announces new editorial leadership

After serving 4 years as co-Editor of the journal Fabio Cominelli, MD, PhD, has been named Editor-in-Chief and Sonia Friedman, MD, FACG, who is joining the editorial leadership, has been named Deputy Editor.

August 6, 2020

Patient groups warn: Administration policy encourages discrimination in health care

Washington, D.C. - Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule.

June 15, 2020

Crohn’s & Colitis Foundation and Pfizer, Inc. Issue RFP to Reduce Health Disparities in Patients with Inflammatory Bowel Disease

NEW YORK, NY – The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer, Inc., announce a Request for Propo

June 2, 2020

Forty-Eight National Health Organizations Urge Congress to Provide Funding for COVID-19 Education for Chronic Illness Communities

NEW YORK, NY – Today, 48 national health organizations sent a letter to members of Congress urging them to fund critical education about COVID-19 and cancelled research activities as a result of the pandemic. 

April 16, 2020

Crohn’s & Colitis Foundation Welcomes New National Trustees

The Crohn’s & Colitis Foundation (the Foundation) is pleased to announce five new members of its National Board of Trustees, which oversees the management of the organization’s policies, practices, principles, affairs, funds, and property.

April 9, 2020

5 Major Advances in Inflammatory Bowel Disease (IBD) Treatment

Breakthrough research from the 2020 Crohn’s & Colitis Congress®, a meeting to transform IBD care.

January 23, 2020